- জেনেরিক নাম
- Ethosuximide
- শক্তি
- 5 gm/100 ml
- ডোজ ফর্ম
- Syrup
- প্রস্তুতকারক
- Advanced Chemical Industries PLC
৳ ১২৭.৭৮ ৳ ১৩০.৩৯ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
Serontin 5 gm/100 ml Syrup একটি সিরাপ ঔষধ, যার জেনেরিক নাম Ethosuximide এবং শক্তি ৫ gm/১০০ ml। Serontin-এর সাথে Ethosuximide-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এটি তৈরি করে Advanced Chemical Industries PLC। দাম: প্রতি ইউনিট ১৩০.৩৯ টাকা। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Serontin syrup is a primary anti-epileptic drug with the active ingredient ethosuximide. It is used to control absence (petit mal) epilepsy, which causes brief spells of lost awareness. The syrup is available as 5 gm/100 ml. Ethosuximide works by reducing the abnormal brain activity that leads to these seizures. It is not for all types of seizures, and a doctor will decide if it is suitable. Treatment is usually started at a low dose and adjusted gradually. Regular blood tests and monitoring may be needed during treatment. Always follow the doctor's instructions and do not stop the medicine suddenly.
Serontin syrup is used for the control of absence (petit mal) epilepsy. This type of epilepsy involves short episodes where a person briefly loses awareness, often staring blankly. The medicine helps reduce the frequency of these seizures. It is not intended for other seizure types unless a doctor advises. The doctor will confirm the diagnosis and decide whether Serontin is appropriate. Use only as prescribed.
Serontin syrup is taken by mouth. The doctor will decide the dose and how often to give it, based on the patient's age, weight, and response. The dose may be started low and increased gradually. Do not change the dose or stop the medicine without asking the doctor, as sudden stopping can be harmful. If a dose is missed, ask the doctor or pharmacist for advice. Shake the bottle if needed and measure with a proper dosing device. Follow the doctor's directions exactly.
Common side effects of ethosuximide include headache, tiredness, drowsiness, dizziness, and unsteadiness. Some people may have hiccups or mild euphoria. Less often, serious effects can occur, such as blood disorders, skin rashes, liver or kidney changes, or gum swelling. Call the doctor right away if you notice unusual bruising or bleeding, fever, sore throat, mouth ulcers, severe rash, or yellowing of the skin or eyes. Also seek help for mood changes, sleep problems, or hyperactivity.
Before using Serontin, tell the doctor about any liver or kidney problems, porphyria, or allergies. This medicine may impair the ability to drive or operate machinery, so avoid these activities until you know how it affects you. Do not stop the medicine suddenly, as this can worsen seizures. The doctor may order periodic blood tests, liver function tests, and urinalysis. Ethosuximide is in pregnancy category C; it should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. It is contraindicated during breastfeeding. Always ask the doctor if you are pregnant, planning pregnancy, or breastfeeding.
Watch for drowsiness, dizziness, headache, or unsteadiness. Call the doctor immediately if you see unusual bruising or bleeding, fever, sore throat, mouth ulcers, severe rash, yellowing of the skin or eyes, or mood changes. These could be signs of serious problems that need medical attention.
Serontin may interact with isoniazid, antipsychotics, antidepressants, MAOIs, mefloquine, carbamazepine, phenobarbital, phenytoin, primidone, valproate, chloroquine, and hydroxychloroquine. These interactions can affect how well the medicine works or increase side effects. Always tell your doctor about all medicines you take, including over-the-counter products.
Ethosuximide is pregnancy category C, meaning it should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. It is contraindicated during breastfeeding. If you are pregnant, planning pregnancy, or breastfeeding, talk to your doctor before using Serontin to discuss risks and alternatives.
No, do not stop Serontin suddenly without talking to your doctor. Sudden withdrawal can increase seizure frequency or cause other problems. Your doctor will advise how to reduce the dose safely if needed. Always follow the prescribed schedule and attend regular check-ups.
৳ ১২৭.৭৮ ৳ ১৩০.৩৯ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ethosuximide is indicated for the control of absence (petit mal) epilepsy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ethosuximide suppresses the paroxysmal three cycle per second spike and wave activity associated with lapses of consciousness which is common in absence (petit mal) seizures. The frequency of epileptiform attacks is reduced, apparently by depression of the motor cortex and elevation of the threshold of the central nervous system to convulsive stimuli.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ethosuximide is administered by the oral route. The initial dose for patients 3 to 6 years of age is 250 mg per day; for patients 6 years of age and older, 500 mg per day. The dose thereafter must be individualized according to the patient's response. Dosage should be increased by small increments. One useful method is to increase the daily dose by 250 mg every four to seven days until control is achieved with minimal side effects. Dosages exceeding 1.5 g daily, in divided doses, should be administered only under the strictest supervision of the physician. The optimal dose for most pediatric patients is 20 mg/kg/day. This dose has given average plasma levels within the acceptedtherapeutic range of 40 to 100 mcg/mL. Subsequent dose schedules can be based on effectiveness and plasma level determinations.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Isoniazid may increase the serum concentration of ethosuximide, leading to toxicity. Antipsychotics, antidepressants, MAOIs, and mefloquine may antagonise anticonvulsant effects of ethosuximide. Plasma conc of ethosuximide may be reduced by carbamazepine, phenobarbital, phenytoin, and primidone; and affected by valproate. Chloroquine or hydroxychloroquine may increase risk of convulsions. Isoniazid.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypersensitivity. Pregnancy and lactation.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Blood toxicities and disorders; headache, fatigue, lethargy, drowsiness, dizziness, ataxia, hiccup and mild euphoria; more rarely, psychotic states, rashes, hepatic and renal changes, and haematological disorders. SLE, erythema multiforme. Gum hypertrophy, swelling of tongue, irritability, hyperactivity, sleep disturbances, night terrors, inability to concentrate, aggressiveness, increased libido, myopia, vag bleeding.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hepatic or renal impairment, porphyria. Complete blood cell count, liver function tests, and urinalysis should be performed periodically. May increase the risk of grand mal seizures when used alone in mixed types of epilepsy. Avoid sudden withdrawal. May impair ability to drive or operate machinery.ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।